Solid Tumors: Genetic Testing & Biomarkers

Modeling Therapy-Induced Tumor Cell State Plasticity to Identify Vulnerabilities for Reducing Disease Burden

Identification of distinct immune signatures in malignant pleural mesothelioma

Unleashing the potential of liquid biopsy in solid tumors: diagnosis, recurrence and resistance

Proteomic and N-glycome profiling of secretome from BRAFV600E mutant colon cancer cells with acquired resistance to vemurafenib

Investigating protein- and gene-expression of 27 cytokines/chemokines in melanoma patients. Identification of a 4-genes signature

Molecular Testing and Liquid Biopsy for Ovarian Cancer

Identification of Novel Biomarkers of Response to Irinotecan in Patients with Colorectal Cancer

Vitiligo and vitiligo-associated markers as indicators of response to immunological checkpoint inhibitors in cutaneous melanoma

Imaging of tumor acidosis for monitoring response to novel anticancer therapies

Tensor-Decomposition-Based Unsupervised Feature Extraction Applied to Prostate Cancer Multiomics Data

The Third Dimension in Prostate Cancer

Apocrine breast carcinoma from biomarkers to therapy

The Evolution of Precision Medicine- Entering the Era of Muliti-omics

A lncRNA signature associated with tumour immune heterogeneity predicts distant metastasis in locoregionally advanced nasopharyngeal carcinoma